Affiliation:
1. Department of Continence Medicine; The University of Tokyo Graduate School of Medicine; Tokyo Japan
2. Department of Urology; The University of Tokyo Graduate School of Medicine; Tokyo Japan
Funder
Kissei Pharmaceutical Co., Ltd.
Ministry of Education, Culture, Sports, Science and Technology
Subject
Urology,Clinical Neurology
Reference25 articles.
1. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH);Roehrborn;Med Clin North Am,2011
2. Alpha-Blockers for benign prostatic hyperplasia: the new era;Lepor;Curr Opin Urol,2012
3. KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model;Akiyama;J Pharmacol Exp Ther,1999
4. Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs;Akiyama;Int J Urol,2001
5. Comparison of silodosin and naftopidil for efficacy in the treatment of benign prostatic enlargement complicated by overactive bladder: a randomized, prospective study (SNIPER study);Matsukawa;J Urol,2017
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献